AC Immune (ACIU) Change in Receivables (2017 - 2025)
AC Immune's (ACIU) quarterly Change in Receivables came in at $751953.0 in Q4 2025, down 97.32% year-on-year from $28.1 million in Q4 2024, and up 1974.17% on a QoQ basis from $36253.2 in Q3 2025.
AC Immune (ACIU) Change in Receivables (2017 - 2025) Analysis & Trends
AC Immune (ACIU) has 8 years of Change in Receivables data on file, last reported at $751953.0 in Q4 2025.
- On a quarterly basis, Change in Receivables fell 97.32% year-over-year to $751953.0 in Q4 2025; TTM through Dec 2025 was $326140.6, a 98.04% decrease from a year earlier, with the FY2025 full-year figure at $217103.1, down 98.71% from the prior year.
- Change in Receivables for Q4 2025 stood at $751953.0, up from $36253.2 in the prior quarter.
- Over the last five years, Change in Receivables for ACIU reached as high as $28.1 million in Q4 2024 and fell as low as -$28.4 million in Q3 2024.
- Historically, Change in Receivables has averaged $29721.1 across 5 years, with a median of $36253.2 in 2025.
- On a YoY basis, Change in Receivables climbed as much as 7713.21% in 2024 and fell as far as 24248.75% in 2024.
- Year by year, Change in Receivables stood at $107471.4 in 2021, then plunged by 166.66% to -$71642.2 in 2022, then slumped by 23167.1% to -$16.7 million in 2023, then soared by 268.46% to $28.1 million in 2024, then sank by 97.32% to $751953.0 in 2025.
- Per Business Quant data, the three most recent Change in Receivables figures were $751953.0 in Q4 2025, $36253.2 in Q3 2025, and $485571.9 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 75.30 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | AC Immune | 222.66 Mn | 222.66 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 751,953.04 |
| Dec 31, 2025 | 751,953.04 |
| Sep 30, 2025 | 36,253.18 |
| Sep 30, 2025 | 36,253.18 |
| Jun 30, 2025 | 485,571.87 |
| Jun 30, 2025 | 485,571.87 |
| Mar 31, 2025 | -947,637.46 |
| Mar 31, 2025 | -947,637.46 |
| Dec 31, 2024 | 28.08 Mn |
| Dec 31, 2024 | 28.08 Mn |
| Sep 30, 2024 | -28.39 Mn |
| Sep 30, 2024 | -28.39 Mn |
| Mar 31, 2024 | 16.96 Mn |
| Mar 31, 2024 | 16.96 Mn |
| Dec 31, 2023 | -16.67 Mn |
| Dec 31, 2023 | -16.67 Mn |
| Sep 30, 2023 | -116,611.71 |
| Sep 30, 2023 | -116,611.71 |
| Jun 30, 2023 | 328,091.79 |
| Jun 30, 2023 | 328,091.79 |